General Biotechnology

Predict the Attack: How to Forecast Paragraph IV Drug Patent Challenge Filings and Neutralize Skinny Label Threats

Predict the Attack: How to Forecast Paragraph IV Filings and Neutralize “Skinny Label” Threats
In pharma, the most expensive surprises rarely arrive with a press release. They arrive quietly—months before launch—inside the legal and regulatory machiner…

Predict the Attack: How to Forecast Paragraph IV Drug Patent Challenge Filings and Neutralize Skinny Label Threats Read Post »

General Biotechnology

Time the Pitch: How Biopharma Packaging BizDev Teams Win by Aligning Child-Resistant Drug Packaging Campaigns with Drug Patent LOE Timeline

Biopharma teams don’t lose deals because they lack ambition—they lose because they mis-time the pitch.
In licensing, partnerships, and BD strategy, timing is everything. But too often, the “when” is treated like a calendar exercise rather than a commer…

Time the Pitch: How Biopharma Packaging BizDev Teams Win by Aligning Child-Resistant Drug Packaging Campaigns with Drug Patent LOE Timeline Read Post »

Biotechblog
Scroll to Top